Advertisement

Topics

Global Drug Analysis: TetraVax-DV – A Potential Best-in-Class Live-Attenuated Vaccine – ResearchAndMarkets.com

09:04 EST 15 Feb 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Drug Analysis: TetraVax-DV” drug pipelines has been added to ResearchAndMarkets.com’s offering. TetraVax-DV is a lyophilized, tetravalent, live-attenuated chimeric vaccine currently in Phase II/III development. The viral strains were formulated by the US National Institutes of Health (NIH) and … Continue reading

Cet article Global Drug Analysis: TetraVax-DV – A Potential Best-in-Class Live-Attenuated Vaccine – ResearchAndMarkets.com est apparu en premier sur Biotech 365.

Original Article: Global Drug Analysis: TetraVax-DV – A Potential Best-in-Class Live-Attenuated Vaccine – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Global Drug Analysis: TetraVax-DV – A Potential Best-in-Class Live-Attenuated Vaccine – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...